Literature DB >> 2748521

Nutrient influences on rat intestinal phenytoin uptake.

D Fleisher1, N Sheth, H Griffin, M McFadden, G Aspacher.   

Abstract

The intestinal uptake of phenytoin was studied as a function of concentration, intestinal region, coperfused glucose, and calcium chloride in rat intestinal perfusions and everted intestinal rings. Steady-state intestinal membrane permeabilities were obtained in an in situ perfusion system and initial rates of intestinal tissue uptake were obtained in an in vitro everted ring system as rate of absorption parameters. Steady-state membrane permeabilities were independent of phenytoin perfusion concentration and decreased from duodenum to ileum. Coperfusion of glucose increased, and high calcium chloride concentrations decreased phenytoin permeabilities. While phenytoin uptake in the in vitro ring system was also concentration-independent and depressed by high calcium concentrations, regional variations and glucose enhancement were not observed. Thus, drug-nutrient interactions involved in intestinal absorption from phenytoin solutions are a function of the isolation procedure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2748521     DOI: 10.1023/a:1015906726365

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Solubility and ionization characteristics of phenytoin.

Authors:  P A Schwartz; C T Rhodes; J W Cooper
Journal:  J Pharm Sci       Date:  1977-07       Impact factor: 3.534

2.  Biology of cell and membrane damage and repair.

Authors:  E D Jacobson
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

3.  Effects of sodium or glucose exclusion from the incubation medium on drug transfer across rat jejunal membrane in vitro: an electrophysiological study.

Authors:  S Yamashita; H Saitoh; K Abe; K Nakanishi; M Masada; T Nadai; T Kimura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1987-08       Impact factor: 1.645

4.  The membrane binding of morphine, diphenylhydantoin, and tetrahydrocannabinol.

Authors:  P Seeman; M Chau-Wong; S Moyyen
Journal:  Can J Physiol Pharmacol       Date:  1972-12       Impact factor: 2.273

5.  Dietary interaction with phenytoin.

Authors:  R C Hatton
Journal:  Clin Pharm       Date:  1984 Mar-Apr

6.  Interference of oral phenytoin absorption by continuous nasogastric feedings.

Authors:  L A Bauer
Journal:  Neurology       Date:  1982-05       Impact factor: 9.910

7.  Liquid-chromatographic method for simultaneous determination of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in plasma and urine.

Authors:  R J Sawchuk; L L Cartier
Journal:  Clin Chem       Date:  1980-06       Impact factor: 8.327

8.  Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds.

Authors:  G L Amidon; P J Sinko; D Fleisher
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

Review 9.  Suitability of urethane anesthesia for physiopharmacological investigations. Part 3: Other systems and conclusions.

Authors:  C A Maggi; A Meli
Journal:  Experientia       Date:  1986-05-15

10.  Increase in membrane fluidity and opening of tight junctions have similar effects on sodium-coupled uptakes in renal epithelial cells.

Authors:  G Friedlander; M Shahedi; C Le Grimellec; C Amiel
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

View more
  8 in total

1.  Intestinal water and solute absorption studies: comparison of in situ perfusion with chronic isolated loops in rats.

Authors:  H H Lu; J D Thomas; J J Tukker; D Fleisher
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

2.  Use of preclinical dog studies and absorption modeling to facilitate late stage formulation bridging for a BCS II drug candidate.

Authors:  Filippos Kesisoglou
Journal:  AAPS PharmSciTech       Date:  2014-02       Impact factor: 3.246

3.  Absorption profiles of sanchinoside R1 and ginsenoside Rg1 in the rat intestine.

Authors:  Feng Liang; Jiang Xue Hua
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

4.  Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model.

Authors:  Filippos Kesisoglou; Simon Yuji Zhou; Susan Niemiec; Jordan Wing Lee; Ellen M Zimmermann; David Fleisher
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

5.  Absorptive clearance of carbamazepine and selected metabolites in rabbit intestine.

Authors:  L E Riad; R J Sawchuk
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

6.  A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.

Authors:  B H Stewart; A R Kugler; P R Thompson; H N Bockbrader
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

Review 7.  Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?

Authors:  H Lennernäs
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

8.  Absorption rate limit considerations for oral phosphate prodrugs.

Authors:  Tycho Heimbach; Doo-Man Oh; Lilian Y Li; Markus Forsberg; Jouko Savolainen; Jukka Leppänen; Yasushi Matsunaga; Gordon Flynn; David Fleisher
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.